Extreme-risk category: High prevalence among stable coronary patients and an emerging widening treatment gap in achieving LDL-cholesterol less than 55 mg/dL

Published 2018 View Full Article

Authors

Keywords

Extreme risk category, Coronary artery disease, LDL cholesterol target, PCSK9-Inhibitor, Statins

Journal

ATHEROSCLEROSIS

Volume 275, Issue -, Pages 262-264

Publisher

Elsevier BV

Online

2018-06-19

DOI

10.1016/j.atherosclerosis.2018.06.821

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started